Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Acidosis and Tumor Progression

Secondary Brain Cancer

Cancer History

Microfluidic cancer treatment screen combined with flow cytometry

What is Tumorigenesis?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

The Cancer Cell Surface Proteome as a Therapeutic Target

What is Cancer of Unknown Primary?

Cancer Symptoms

What is Immunochemotherapy?

What is Cancer?

See more featured articles »

Cancer Glossary

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

What Causes Cancer?

Cancer Diagnosis

Insights into Oncofertility

Cancer Screening Considerations: Balancing the Benefits and Risks

Using Biomarkers to Detect Cancer

Cutaneous Manifestations of Internal Malignancy

Exploiting Enzymes in Cancer Diagnosis and Therapy

What is the Tumor Microenvironment?

British Pioneers in Cancer Biology

Hot vs Cold: the differences between tumor types

Insight into Cancer Vaccines

Cancer Prognosis

Cancer Classification

Myc Mutations and Cancer

Cancer Pain

Effects of Social and Economic Deprivation on Cancer Mortality

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Pediatric Cancer

Hypoxia Markers and Their Importance

Secondary Lung Cancer

Extracellular Vesicles as Floating Cancer Biomarkers

Metastatic Migration in Cancer may be Influenced by Metabolism

CDK9 and Cancer

Living with Cancer Pain

Caring for a Loved One with Cancer

Cancer Epidemiology

What Role do Biobanks Play in Cancer Research?

Is Cancer a Metabolic Disorder?

The Effects of Cancer on Family Life

Investigating the Molecular Mechanisms of Cancer

Transforming Cancer Care through Genomic Testing

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Prevention: Lowering your Risk

Why are Cancer Cell Lines Useful?

Cancer Pain Management

Cancer Management

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

The Biochemistry of Breast Cancer Screening

Overview of Cell Viability and Cytotoxicity

Targeted Cancer Therapies

Cancer Research

Cancer Pathophysiology

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

What is Merkel Cell Carcinoma?

TARDIS: The Improved Method of Detecting Breast Cancer

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Latest Cancer News and Research

UK study identifies ways to improve bowel cancer detection in IBD patients

The first UK-wide analysis of bowel screening for patients with inflammatory bowel disease (IBD) has identified opportunities to improve the early detection of cancer.

27 Oct 2026

Lab-on-a-chip technology helps predict childhood leukemia treatment responses

More than 120,000 people in the U.S. are living with acute lymphoblastic leukemia (ALL), and 6,000 new cases are diagnosed each year. Of those, more than 3,500 will be in children.

27 Oct 2026

New research center aims to accelerate hepatitis C vaccine development

The shifty hepatitis C virus (HCV) has a knack for outmaneuvering the immune system. Its secret is an especially high mutation rate, which has generated an abundance of viral variants with extreme genetic diversity.

27 Oct 2026

Men with lower testosterone at 31 reported good health 15 years later

Researchers analyzed testosterone concentrations measured at age 31 in 2,691 Finnish men and assessed self-reported health, medical conditions, and quality of life at age 46. Men across testosterone quartiles generally reported good health and excellent quality of life, while differences in metabolic and gastrointestinal conditions lost statistical significance after adjustment for waist circumference.

27 Oct 2026

Updated ASTRO guidelines recommend shorter radiation courses for prostate cancer

An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of hypofractionated radiation therapy for patients with localized prostate cancer.

27 Oct 2026

Baylor researchers discover how glioblastoma hijacks nearby brain cells

Researchers at Baylor College of Medicine have discovered a new strategy that glioblastoma, the most common and aggressive form of adult brain cancer, uses to fuel its own growth.

27 Oct 2026

Endometrial cancer rates rise sharply among younger South Texas women

An Upper-South region of Texas including San Antonio and Bexar County had the state's highest hysterectomy-corrected incidence of endometrial cancer and the largest increase over time, a study led by scientists at The University of Texas at San Antonio Health Science Center and the National Cancer Institute showed.

27 Oct 2026

First human endothelial cell atlas maps how blood vessels age

To uncover how endothelial cells, the inner linings of blood vessels. change over the course of a lifespan, an international research team led by Laura de Rooij at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences has created the Human Aging Endothelial Cell Atlas, the first comprehensive atlas of vascular aging.

27 Oct 2026

Blocking cellular communication reduces the spread of deadly glioblastoma

In a new study published in Cancer Cell, researchers at VIB-KU Leuven reduced the spread of glioblastoma by interrupting specific interactions between the brain's immune cells and tumor cells.

27 Oct 2026

NCCN releases first-ever guide for cancer caregivers

Today, the National Comprehensive Cancer Network (NCCN)-an alliance of leading cancer centers in the United States responsible for guidelines that patients and providers rely on worldwide to improve outcomes-published its first-ever NCCN Guidelines for Patients focused specifically on how to support loved ones with cancer.

27 Oct 2026

More Americans now know alcohol increases future cancer risks

Nearly 6 in 10 Americans (58%) know that regularly consuming alcohol increases the chances of later developing cancer, according to a nationally representative survey in October by the Annenberg Public Policy Center (APPC), a statistically significant increase of five percentage points since February 2026.

27 Oct 2026

Vitamin B5 derivative pantethine helps prevent and alleviate psoriasis symptoms in mice

Researchers in China have discovered that the vitamin B5 derivative pantethine limits the activity of immune cells that are key contributors to autoimmune diseases such as psoriasis.

27 Oct 2026

Breakthrough targeted therapy shows strong precision in treating chronic myeloid leukemia

A more effective and better-tolerated treatment for chronic myeloid leukemia (CML) could improve quality of life for people living with the disease.

27 Oct 2026

Machine learning models predict common cancer risks using routine health data

Machine learning models using routinely collected health information, such as blood tests, medical history and lifestyle factors, could help identify people at higher risk of several common cancers, according to an international study reported at the ESMO Congress 2026.

27 Oct 2026

Patients with a form of advanced lung cancer lived 56 percent longer without their disease progressing after receiving radiotherapy in addition to standard treatment

Patients with an advanced form of lung cancer lived 56 percent longer without their disease progressing when radiotherapy was added to the standard of care whole-body therapy, including chemotherapy and/or immunotherapy, according to initial results from a clinical trial presented at the 2026 European Society for Medical Oncology (ESMO) Congress.

27 Oct 2026

Terumo Blood and Cell Technologies and Ribeirão Preto Blood Center automate blood processing in Brazil

Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company and global leader in blood management solutions, announced the adoption of multiple Reveos™ Automated Blood Processing Systems by Ribeirão Preto Blood Center, the high-volume blood network supporting about 120,000 transfusions a year in São Paulo.

27 Oct 2026

Study establishes new perioperative standard in prostate cancer

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer with apalutamide - a next-generation neoadjuvant androgen-receptor pathway inhibitor (ARPI) - plus hormone therapy before and after prostate cancer surgery, was further validated by a substudy demonstrating a reduced risk of metastasis or death compared with standard of care.

27 Oct 2026

Cerebrospinal fluid liquid biopsy detects tumor DNA in complex brain cases

A Mayo Clinic study published in the Journal of Neuro-Oncology suggests that analyzing DNA in cerebrospinal fluid could provide another source of information when MRI cannot provide a clear brain tumor diagnosis or obtaining tissue through biopsy is difficult or potentially unsafe.

27 Oct 2026

New model reduces trial and error in mass spectrometry imaging

Andrei Fedorov and his team have found a way to take some of the guesswork out of mass spectrometry imaging (MSI), potentially giving scientists better tools to explore the molecules that influence our health.

27 Oct 2026

New alpha-emitting radiopharmaceutical therapy achieves strong responses in advanced prostate cancer

A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting toxicities observed, and showed encouraging signs of antitumor activity, according to a phase 1 trial published in The Journal of Nuclear Medicine's Late-Breaking Fast Track.

26 Oct 2026